NFATC1 and non-small cell lung carcinoma: Besides, our results revealed that NFATc1 overexpression partially abolished the effects of miR‐338 mimic on the proliferation of NSCLC cells and reversed miR‐338 caused EMT‐related marker changes, indicating that miR‐338 could modulate NSCLC progression by directly targeting NFATc1.